Inhibition of Na+/H+-exchanger with sabiporide attenuates the downregulation and uncoupling of the myocardial beta-adrenoceptor system in failing rabbit hearts

British Journal of Pharmacology
Kirsten LeineweberRainer Schulz

Abstract

Chronic heart failure (HF) is characterized by left ventricular (LV) structural remodeling, impaired function, increased circulating noradrenaline (NA) levels and impaired responsiveness of the myocardial beta-adrenoceptor (betaAR)-adenylyl cyclase (AC) system. In failing hearts, inhibition of the sodium/proton-exchanger (NHE)-1 attenuates LV remodeling and improves LV function. The mechanism(s) involved in these cardioprotective effects remain(s) unclear, but might involve effects on the impaired betaAR-AC system. Therefore, we investigated whether NHE-1 inhibition with sabiporide (SABI; 30 mg kg(-1) day(-1) p.o.) might affect myocardial betaAR density and AC activity in relation to changes in LV end-diastolic diameter (LVEDD) and LV systolic fractional shortening (LVS-FS) after 3 weeks of rapid LV pacing in rabbits. After 3 weeks of rapid LV pacing LVEDD was significantly increased (Shams 17+/-0.2 mm, n=9 vs 3 wksHF 20+/-0.5 mm, n=8; P<0.05) and LVS-FS decreased (Shams 31+/-1%, n=9 vs 3 wksHF 10+/-1%, n=8; P<0.05). SABI treatment significantly improved LV function independent of whether rabbits were treated after 1 week of pacing (3 wksHF+2 wksSABI (n=7): LVEDD 18+/-1 mm; LVS-FS 16+/-4%) or before pacing (3 wksHF+3wksSABI (n=...Continue Reading

References

Nov 1, 1992·The American Journal of Physiology·M A Wallert, O Fröhlich
Feb 28, 1992·Biochemical and Biophysical Research Communications·M GuptaR Zak
Apr 1, 1974·Analytical Biochemistry·Y SalomonM Rodbell
Jul 22, 1982·The New England Journal of Medicine·M R BristowE B Stinson
May 1, 1994·The Journal of Clinical Investigation·Y IshikawaC J Homcy
Mar 1, 1993·The Journal of Clinical Investigation·K KiuchiD E Vatner
Mar 1, 1993·Cardiovascular Research·G LarosaC Forster
Oct 17, 1996·The New England Journal of Medicine·J NarulaB A Khaw
Apr 17, 1997·The New England Journal of Medicine·G OlivettiP Anversa
Jan 1, 1997·Basic Research in Cardiology·G HasenfussH Just
Aug 1, 1997·The American Journal of Physiology·P PingH K Hammond
Dec 31, 1997·The American Journal of Cardiology·M R Bristow
May 29, 1998·Journal of Molecular and Cellular Cardiology·K D SchlüterH M Piper
Jan 12, 1999·Cellular Signalling·T YamazakiY Yazaki
Jun 9, 1999·Proceedings of the National Academy of Sciences of the United States of America·S EngelhardtM J Lohse
Aug 12, 1999·European Journal of Pharmacology·C GiesslerO E Brodde
Sep 11, 1999·The American Journal of Cardiology·M Avkiran
Jan 25, 2000·American Journal of Physiology. Heart and Circulatory Physiology·H Yoshida, M Karmazyn
Apr 25, 2000·American Journal of Physiology. Heart and Circulatory Physiology·H KawaiC S Liang
Feb 13, 2001·American Journal of Physiology. Heart and Circulatory Physiology·K KusumotoM Karmazyn
Feb 22, 2001·Journal of Molecular and Cellular Cardiology·C MoriscoJ Sadoshima
May 10, 2001·Journal of Molecular and Cellular Cardiology·J D Port, M R Bristow
Feb 6, 2002·Cardiovascular Research·Andrew K SnabaitisMetin Avkiran
Mar 30, 2002·Cardiovascular Research·María C Camilión de HurtadoHoracio E Cingolani
Feb 8, 2003·Hypertension·Horacio E CingolaniMaría C Camilión de Hurtado

❮ Previous
Next ❯

Citations

Mar 2, 2011·Basic Research in Cardiology·Fatima MraicheLarry Fliegel
Jan 4, 2012·Basic Research in Cardiology·Jakob VoelklFlorian Lang
Nov 3, 2010·Circulation Journal : Official Journal of the Japanese Circulation Society·Gerd Heusch
Jun 7, 2013·Basic Research in Cardiology·Stefan Neef, Lars S Maier

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.